Urology Today.net

Site updated at Thursday, 12 May 2016

Common Urological Problems

Immunotherapy

Mayo Clinic researchers use human vaccine to cure prostate cancer in mice

Mayo Clinic investigators and collaborators from the United Kingdom cured well-established prostate tumors in mice using a human vaccine with no apparent side effects. This novel cancer treatment approach encourages the immune system to rid itself of prostate tumors without assistance from toxic chemotherapies and radiation treatments. Such a treatment model could some day… Mayo Clinic researchers use human vaccine to cure prostate cancer in mice   



Bristol’s Yervoy falls short in prostate cancer study

Bristol-Myers Squibb Co’s immunotherapy drug Yervoy failed to significantly prolong survival among patients with advanced prostate cancer who had previously received chemotherapy, according to limited data from the first late-stage study of the drug for the condition.

Yervoy (ipilimumab) frees the immune system to attack and kill cancer cells by blocking the action of… Bristol’s Yervoy falls short in prostate cancer study   



carboplatin1 - ungal1 - zygote intrafallopian transfer1 - low-grade prostate cancer2 - annual screening1 - osteoporosis1 - radiation therapy oncology group1 - running1 - urinary total arsenic level1 - bladder ulcer1 - sex life1 - bloody diarrhea1 - external genitalia1 - triage1 - cerebral palsy1 - prostate screening3 - low testosterone1 - complex diverticula1 - adolescent overweight1 - finasteride1 - pet1 - urinary frequency6 - gastrointestinal tract1 - interstitium1 - donor kidney1 - lower urinary tract symptomս1 - albumin in the urine1 - journal of oncology practice1 - androgen receptor1 - american cancer society1 -